In The News Posted September 1, 2022 Share Posted September 1, 2022 EAST RUTHERFORD, New Jersey, 1er septembre 2022 /PRNewswire/ -- Cambrex a annoncé aujourd'hui l'achèvement de la première phase de son investissement de 30 millions de dollars dans son usine de fabrication de principes actifs pharmaceutiques (API) à petites molécules à High Point, en...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now